Prediction of protein-protein interactions and co-complex models with deep learning
Clinical Snapshot
PICO Framework
| P — Population | Not applicable in the clinical sense; the 'population' is the body of computational and experimental literature on protein-protein interactions (PPIs) across proteome-wide PPI prediction, PPI interface prediction, and PPI co-complex structure prediction tasks |
| I — Intervention | Deep learning-based computational methods for PPI prediction, interface prediction, and co-complex structure prediction |
| C — Comparator | Earlier non-deep-learning computational approaches (e.g., sequence-based, structure-based, and classical machine learning methods) and experimental PPI mapping techniques |
| O — Outcomes | Methodological performance (accuracy, precision, recall, structural quality metrics), biological applicability, and biomedical utility of deep learning PPI prediction frameworks |
Bottom Line
This narrative review from Cornell University's computational biology group provides a well-structured expert synthesis of deep learning approaches to protein-protein interaction (PPI) prediction, interface prediction, and co-complex structure modelling. It offers a useful conceptual taxonomy of methodological paradigms and honestly discusses the strengths and limitations of current tools. However, it is not a systematic review and does not meet CEBM criteria for high-quality evidence synthesis: there is no registered protocol, no systematic search strategy, no formal quality assessment of included studies, and no quantitative pooling of performance metrics. The CEBM score of 20/100 reflects the review format rather than the scientific quality of the underlying field. For senior clinicians and translational researchers, this paper is best read as an expert opinion and field orientation piece rather than a definitive evidence base. The translational pathway from deep learning PPI prediction to clinical application remains indirect and requires prospective validation in disease-relevant biological systems before informing clinical decision-making or drug development strategy.
Key Findings
P Value: Not reported
Effect Size: Not applicable — no pooled quantitative effect size reported; individual method performance metrics are referenced descriptively without meta-analytic synthesis
Primary Outcome: Qualitative synthesis of deep learning methodological paradigms for three PPI tasks: proteome-wide PPI prediction, PPI interface prediction, and PPI co-complex structure prediction
Nnt Or Sensitivity: Not applicable in the clinical sense; individual deep learning tools report varying AUROC, precision-recall, and structural quality metrics (e.g., TM-score, DockQ) that are discussed qualitatively but not pooled
Confidence Interval: Not reported
Clinical Application
Implementation of reviewed deep learning tools (e.g., AlphaFold2-Multimer, ESMFold-based interaction predictors) requires significant computational infrastructure (GPU clusters, specialised bioinformatics pipelines) and domain expertise. These are not bedside or point-of-care tools. Feasibility in clinical research settings depends on institutional computational biology capacity. Direct PBS or TGA relevance is not applicable at this stage. However, Australian research institutions (e.g., WEHI, Garvan Institute, QIMR Berghofer) and pharmaceutical industry partners are active users of PPI prediction tools in drug discovery. The Australian Government's Medical Research Future Fund (MRFF) supports translational genomics and structural biology initiatives where these methods are increasingly relevant. RACGP guidelines are not applicable. Future relevance may emerge in precision oncology and rare disease diagnostics as PPI-informed drug targets progress through clinical pipelines. Not directly applicable to patient care at present. The primary audience is computational biologists, structural biologists, and translational researchers working on protein interaction networks, drug target identification, and disease mechanism elucidation. Indirect clinical relevance exists for oncology, rare disease genomics, and drug discovery pipelines.
Abstract
Protein-protein interactions (PPIs) are fundamental to cellular processes, and essential for understanding biological function and disease mechanisms. In this review, we emphasize recent deep learning-based methods for protein interaction study. Focusing on three closely related tasks of proteome-wide PPI prediction, PPI interface prediction, and PPI co-complex structure prediction, we discuss how emerging concepts and computation approaches have evolved to shape these fields We categorize recent approaches according to their methodological paradigms, summarize their strengths and limitations, and further explore diverse biological and biomedical applications, highlighting how computational methods in PPI prediction, PPI interface prediction, and PPI structure prediction jointly contribute to understanding of complex biological systems.
References
- 1.Zhang, Z., Liu, Y., & Yu, H. (2026). Prediction of protein-protein interactions and co-complex models with deep learning. Current Opinion in Chemical Biology. https://doi.org/10.1016/j.cbpa.2026.102703
Related Research
Journal of chemical information and modeling
ProphDR: An Interpretable Deep Learning Model for Predicting Cancer Drug Response via Multi-Omics and Cross-Attention Mechanisms
28 July 2026
PloS one
Multi-view graph-regularized deep metric subspace clustering network
26 July 2026
New biotechnology
Harnessing AI to decode protein kinases: Structural, functional, and therapeutic design perspectives.
25 July 2026
This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service